NASDAQ:ALNY - Alnylam Pharmaceuticals SEC Filings & 10K Form

$72.79
+1.25 (+1.75 %)
(As of 07/15/2019 04:00 PM ET)
Today's Range
$71.15
Now: $72.79
$73.59
50-Day Range
$67.52
MA: $71.03
$74.37
52-Week Range
$60.27
Now: $72.79
$124.21
Volume592,400 shs
Average Volume873,410 shs
Market Capitalization$7.75 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.5

SEC Filings

Alnylam Pharmaceuticals (NASDAQ:ALNY) SEC Filings

DateFilerForm TypeView
07/11/2019
3:15 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/05/2019
9:07 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
View Filing
07/02/2019
3:05 PM
Alnylam Pharmaceuticals (Issuer)
Fanucci Marsha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/02/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Ausiello Dennis A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/07/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/21/2019
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/03/2019
3:02 PM
Alnylam Pharmaceuticals (Subject)
Sanofi (Filed by)
Form SC 13G/A
View Filing
05/02/2019
8:59 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/02/2019
8:58 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/01/2019
7:45 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/26/2019
3:32 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/17/2019
3:05 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/10/2019
5:05 AM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/09/2019
3:43 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/08/2019
3:24 PM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
View Filing
03/21/2019
6:30 AM
Alnylam Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/11/2019
4:07 PM
Alnylam Pharmaceuticals (Filer)
Form PRE 14A
View Filing
03/01/2019
5:11 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2019
5:09 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2019
5:09 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/14/2019
12:04 PM
Alnylam Pharmaceuticals (Subject)
DODGE & COX (Filed by)
Form SC 13G/A
View Filing
02/11/2019
11:46 AM
Alnylam Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/07/2019
3:15 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/31/2019
2:09 PM
Alnylam Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
View Filing
01/22/2019
2:13 PM
Alnylam Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/15/2019
4:19 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/15/2019
4:14 PM
Alnylam Pharmaceuticals (Filer)
Form 424B5
View Filing
01/14/2019
3:41 PM
Alnylam Pharmaceuticals (Filer)
Form 424B5
View Filing
01/11/2019
3:07 PM
Alnylam Pharmaceuticals (Issuer)
HAMBURG MARGARET A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/11/2019
3:06 PM
Alnylam Pharmaceuticals (Issuer)
HAMBURG MARGARET A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
01/07/2019
7:11 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/10/2018
4:19 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/26/2018
3:11 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/07/2018
3:32 PM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/07/2018
7:16 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/10/2018
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/28/2018
3:59 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/28/2018
3:58 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/28/2018
3:57 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/28/2018
3:56 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/28/2018
3:55 PM
Alnylam Pharmaceuticals (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/28/2018
3:54 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/12/2018
4:16 PM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
View Filing
09/04/2018
3:15 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/23/2018
3:15 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/23/2018
3:15 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/23/2018
3:15 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/23/2018
3:14 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/23/2018
3:13 PM
Alnylam Pharmaceuticals (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/17/2018
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/14/2018
6:14 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
5:55 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
5:33 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
5:21 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
5:05 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
5:00 PM
Alnylam Pharmaceuticals (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/14/2018
4:54 PM
Alnylam Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/10/2018
2:45 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/02/2018
4:23 PM
Alnylam Pharmaceuticals (Filer)
Form S-8 POS
View Filing
08/02/2018
4:20 PM
Alnylam Pharmaceuticals (Filer)
Form S-8 POS
View Filing
08/02/2018
4:18 PM
Alnylam Pharmaceuticals (Filer)
Form S-8 POS
View Filing
08/02/2018
4:14 PM
Alnylam Pharmaceuticals (Filer)
Form S-8 POS
View Filing
08/02/2018
4:10 PM
Alnylam Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
View Filing
08/02/2018
7:46 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/02/2018
7:15 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/27/2018
3:07 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:20 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:20 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:19 PM
Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:19 PM
Alnylam Pharmaceuticals (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:19 PM
Alnylam Pharmaceuticals (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:18 PM
Alnylam Pharmaceuticals (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:18 PM
Alnylam Pharmaceuticals (Issuer)
Fanucci Marsha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:18 PM
Alnylam Pharmaceuticals (Issuer)
CLARKE JOHN K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:17 PM
Alnylam Pharmaceuticals (Issuer)
BONNEY MICHAEL W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:17 PM
Alnylam Pharmaceuticals (Issuer)
Ausiello Dennis A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/11/2018
9:18 AM
Alnylam Pharmaceuticals (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
View Filing
06/05/2018
3:50 PM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
View Filing
06/04/2018
3:44 PM
Alnylam Pharmaceuticals (Issuer)
Reitan Colleen F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/04/2018
3:32 PM
Alnylam Pharmaceuticals (Issuer)
Reitan Colleen F (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
05/10/2018
9:47 AM
Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
View Filing
05/04/2018
4:04 PM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
04/20/2018
4:21 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/03/2018
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/28/2018
3:39 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/23/2018
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/22/2018
5:18 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
4:05 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/16/2018
4:05 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
6:40 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
6:40 PM
Alnylam Pharmaceuticals (Issuer)
Ausiello Dennis A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
6:39 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
6:39 PM
Alnylam Pharmaceuticals (Issuer)
SCHIMMEL PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 7/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel